| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1347615 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of INSIG1 mRNA | CTD | PMID:22079256 |
| (S)-nicotine | increases expression | ISO | RGD:1347615 | 6480464 | Nicotine results in increased expression of INSIG1 mRNA | CTD | PMID:23416264 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1347615 | 6480464 | Ethinyl Estradiol affects the expression of INSIG1 mRNA | CTD | PMID:20170705 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:708457 | 6480464 | Ethinyl Estradiol results in decreased expression of INSIG1 mRNA | CTD | PMID:17108234 PMID:15901920 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1347615 | 6480464 | Ethinyl Estradiol results in increased expression of INSIG1 mRNA | CTD | PMID:18936297 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:708457 | 6480464 | Ethinyl Estradiol results in decreased expression of INSIG1 mRNA | CTD | PMID:15901920 PMID:17108234 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:708457 | 6480464 | Ethinyl Estradiol affects the expression of INSIG1 mRNA | CTD | PMID:20170705 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of INSIG1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | affects expression | ISO | RGD:1347615 | 6480464 | Estradiol affects the expression of INSIG1 mRNA | CTD | PMID:21826169 |
| 17beta-estradiol | increases expression | ISO | RGD:1347615 | 6480464 | Estradiol results in increased expression of INSIG1 mRNA | CTD | PMID:19167446 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | ISO | RGD:1347615 | 6480464 | Metribolone results in increased expression of INSIG1 mRNA; more ... | CTD | PMID:16751804 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1347615 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of INSIG1 mRNA | CTD | PMID:12377990 PMID:16704738 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of INSIG1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:708457 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of INSIG1 mRNA | CTD | PMID:20558275 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1347615 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of INSIG1 mRNA | CTD | PMID:21998131 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1347615 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of INSIG1 mRNA | CTD | PMID:16704738 PMID:12377990 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of INSIG1 mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of INSIG1 mRNA | CTD | PMID:17942748 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:708457 | 6480464 | 2,4-dinitrotoluene affects the expression of INSIG1 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:708457 | 6480464 | 2,6-dinitrotoluene affects the expression of INSIG1 mRNA | CTD | PMID:21346803 |
| 2-butoxyethanol | increases expression | EXP | | 6480464 | n-butoxyethanol results in increased expression of INSIG1 mRNA | CTD | PMID:19812364 |
| 2-methylcholine | affects expression | ISO | RGD:1347615 | 6480464 | beta-methylcholine affects the expression of INSIG1 mRNA | CTD | PMID:21179406 |
| 25-hydroxycholesterol | decreases expression | EXP | | 6480464 | 25-hydroxycholesterol results in decreased expression of INSIG1 mRNA | CTD | PMID:19260826 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:1347615 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of INSIG1 mRNA | CTD | PMID:23146750 |
| 3,3',5-triiodo-L-thyronine | increases expression | ISO | RGD:708457 | 6480464 | Triiodothyronine results in increased expression of INSIG1 mRNA | CTD | PMID:15953391 |
| 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:708457 | 6480464 | 1,2-dithiol-3-thione results in decreased expression of INSIG1 mRNA | CTD | PMID:19162173 |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1347615 | 6480464 | decitabine results in decreased expression of INSIG1 mRNA | CTD | PMID:19194470 |
| 5-fluorouracil | increases expression | ISO | RGD:1347615 | 6480464 | Fluorouracil results in increased expression of INSIG1 mRNA | CTD | PMID:17039268 |
| 7,12-dimethyltetraphene | affects expression | EXP | | 6480464 | 9,10-Dimethyl-1,2-benzanthracene affects the expression of INSIG1 mRNA | CTD | PMID:21785161 |
| 7,12-dimethyltetraphene | decreases expression | ISO | RGD:708457 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of INSIG1 mRNA | CTD | PMID:12376462 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:1347615 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of INSIG1 mRNA | CTD | PMID:22079614 |
| acetylsalicylic acid | increases expression | ISO | RGD:1347615 | 6480464 | Aspirin results in increased expression of INSIG1 mRNA | CTD | PMID:15928584 |
| acetylsalicylic acid | increases expression | ISO | RGD:708457 | 6480464 | Aspirin results in increased expression of INSIG1 mRNA | CTD | PMID:12800193 |
| aflatoxin B1 | affects expression | ISO | RGD:1347615 | 6480464 | Aflatoxin B1 affects the expression of INSIG1 protein | CTD | PMID:20106945 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of INSIG1 mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1347615 | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in decreased expression of INSIG1 mRNA | CTD | PMID:15894607 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1347615 | 6480464 | Tretinoin results in decreased expression of INSIG1 mRNA | CTD | PMID:15894607 |
| ammonium chloride | affects expression | ISO | RGD:708457 | 6480464 | Ammonium Chloride affects the expression of INSIG1 mRNA | CTD | PMID:16483693 |
| benzene | affects expression | ISO | RGD:708457 | 6480464 | Benzene affects the expression of INSIG1 mRNA | CTD | PMID:15878777 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of INSIG1 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | affects expression | EXP | | 6480464 | Benzo(a)pyrene affects the expression of INSIG1 mRNA | CTD | PMID:22342234 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of INSIG1 mRNA] | CTD | PMID:22228805 |
| bezafibrate | increases expression | EXP | | 6480464 | Bezafibrate results in increased expression of INSIG1 mRNA | CTD | PMID:17118139 |
| bezafibrate | increases expression | EXP | | 6480464 | Bezafibrate results in increased expression of INSIG1 mRNA | CTD | PMID:17118139 PMID:19124612 |
| bezafibrate | increases expression | EXP | | 6480464 | Bezafibrate results in increased expression of INSIG1 mRNA | CTD | PMID:19124612 PMID:17118139 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:708457 | 6480464 | Diethylhexyl Phthalate results in decreased expression of INSIG1 mRNA | CTD | PMID:15728792 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of INSIG1 mRNA | CTD | PMID:21932408 |
| bisphenol A | affects expression | ISO | RGD:1347615 | 6480464 | bisphenol A affects the expression of INSIG1 mRNA | CTD | PMID:20170705 PMID:21826169 |
| bisphenol A | affects expression | ISO | RGD:1347615 | 6480464 | bisphenol A affects the expression of INSIG1 mRNA | CTD | PMID:20170705 |
| bisphenol A | increases expression | ISO | RGD:708457 | 6480464 | bisphenol A results in increased expression of INSIG1 mRNA | CTD | PMID:12075121 |
| bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of INSIG1 mRNA | CTD | PMID:21932408 |
| bisphenol A | affects expression | ISO | RGD:1347615 | 6480464 | bisphenol A affects the expression of INSIG1 mRNA | CTD | PMID:21826169 PMID:20170705 |
| butyric acid | increases expression | ISO | RGD:708457 | 6480464 | Butyric Acid results in increased expression of INSIG1 mRNA | CTD | PMID:12800193 |
| cadmium dichloride | increases expression | ISO | RGD:708457 | 6480464 | Cadmium Chloride results in increased expression of INSIG1 mRNA | CTD | PMID:19010381 |
| cadmium sulfate | multiple interactions | ISO | RGD:1347615 | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of INSIG1 mRNA | CTD | PMID:18654764 |
| caffeine | decreases expression | ISO | RGD:708457 | 6480464 | Caffeine results in decreased expression of INSIG1 mRNA | CTD | PMID:20864626 |
| calcitriol | multiple interactions | ISO | RGD:1347615 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of INSIG1 mRNA | CTD | PMID:21592394 |
| calcitriol | increases expression | ISO | RGD:1347615 | 6480464 | Calcitriol results in increased expression of INSIG1 mRNA | CTD | PMID:21592394 |
| carmustine | decreases expression | ISO | RGD:1347615 | 6480464 | Carmustine results in decreased expression of INSIG1 mRNA | CTD | PMID:15980968 |
| celastrol | increases expression | ISO | RGD:1347615 | 6480464 | tripterine results in increased expression of INSIG1 mRNA | CTD | PMID:17010675 |
| chloroethene | increases expression | EXP | | 6480464 | Vinyl Chloride results in increased expression of INSIG1 mRNA | CTD | PMID:18579281 |
| ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of INSIG1 mRNA | CTD | PMID:18353800 |
| cisplatin | multiple interactions | ISO | RGD:1347615 | 6480464 | Cisplatin affects the reaction [Piroxicam results in decreased expression of INSIG1 mRNA] | CTD | PMID:21858171 |
| clofibrate | increases expression | ISO | RGD:708457 | 6480464 | Clofibrate results in increased expression of INSIG1 mRNA | CTD | PMID:17126302 |
| clofibrate | increases expression | ISO | RGD:708457 | 6480464 | Clofibrate results in increased expression of INSIG1 mRNA | CTD | PMID:17126302 PMID:12851107 |
| clofibrate | increases expression | ISO | RGD:708457 | 6480464 | Clofibrate results in increased expression of INSIG1 mRNA | CTD | PMID:12851107 PMID:17126302 |
| cobalt dichloride | multiple interactions | ISO | RGD:1347615 | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of INSIG1 mRNA | CTD | PMID:18654764 |
| cobalt dichloride | increases expression | ISO | RGD:1347615 | 6480464 | cobaltous chloride results in increased expression of INSIG1 mRNA | CTD | PMID:19376846 |
| copper atom | multiple interactions | ISO | RGD:1347615 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of INSIG1 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1347615 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of INSIG1 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | increases expression | ISO | RGD:1347615 | 6480464 | Copper Sulfate results in increased expression of INSIG1 mRNA | CTD | PMID:19549813 |
| coumestrol | increases expression | ISO | RGD:1347615 | 6480464 | Coumestrol results in increased expression of INSIG1 mRNA | CTD | PMID:19167446 |
| coumestrol | multiple interactions | ISO | RGD:1347615 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of INSIG1 mRNA; more ... | CTD | PMID:19167446 |
| cyclosporin A | decreases expression | ISO | RGD:1347615 | 6480464 | Cyclosporine results in decreased expression of INSIG1 mRNA | CTD | PMID:20106945 |
| desmosterol | decreases expression | EXP | | 6480464 | Desmosterol results in decreased expression of INSIG1 protein | CTD | PMID:19260826 |
| diarsenic trioxide | decreases expression | ISO | RGD:1347615 | 6480464 | arsenic trioxide results in decreased expression of INSIG1 mRNA | CTD | PMID:15894607 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1347615 | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in decreased expression of INSIG1 mRNA | CTD | PMID:15894607 |
| dibutyl phthalate | decreases expression | ISO | RGD:708457 | 6480464 | Dibutyl Phthalate results in decreased expression of INSIG1 mRNA | CTD | PMID:15728792 PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:708457 | 6480464 | Dibutyl Phthalate results in decreased expression of INSIG1 mRNA | CTD | PMID:21266533 PMID:15728792 |
| dipentyl phthalate | decreases expression | ISO | RGD:708457 | 6480464 | di-n-pentyl phthalate results in decreased expression of INSIG1 mRNA | CTD | PMID:15728792 |
| ethanol | multiple interactions | ISO | RGD:708457 | 6480464 | [Fish Oils co-treated with Ethanol] results in increased expression of INSIG1 mRNA | CTD | PMID:17347304 |
| etoposide | affects response to substance | ISO | RGD:1347615 | 6480464 | INSIG1 protein affects the susceptibility to Etoposide | CTD | PMID:16217747 |
| fluoxetine | increases expression | ISO | RGD:708457 | 6480464 | Fluoxetine results in increased expression of INSIG1 mRNA | CTD | PMID:21852994 |
| folic acid | increases expression | ISO | RGD:1347615 | 6480464 | Folic Acid results in increased expression of INSIG1 mRNA | CTD | PMID:11723236 |
| fructose | decreases expression | EXP | | 6480464 | Fructose results in decreased expression of INSIG1 protein | CTD | PMID:22698815 |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of INSIG1 mRNA | CTD | PMID:22698815 |
| fructose | multiple interactions | EXP | | 6480464 | Phenylbutyrates inhibits the reaction [Fructose results in decreased expression of INSIG1 protein] | CTD | PMID:22698815 |
| gedunin | increases expression | ISO | RGD:1347615 | 6480464 | gedunin results in increased expression of INSIG1 mRNA | CTD | PMID:17010675 |
| genistein | increases expression | ISO | RGD:1347615 | 6480464 | Genistein results in increased expression of INSIG1 mRNA | CTD | PMID:18847459 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1347615 | 6480464 | [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of INSIG1 mRNA | CTD | PMID:18032389 |
| indole-3-methanol | multiple interactions | ISO | RGD:708457 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of INSIG1 mRNA | CTD | PMID:22129741 |
| isotretinoin | decreases expression | ISO | RGD:1347615 | 6480464 | Isotretinoin results in decreased expression of INSIG1 mRNA | CTD | PMID:20436886 |
| linalool | increases expression | EXP | | 6480464 | linalool results in increased expression of INSIG1 protein | CTD | PMID:21944868 |
| linalool | increases expression | ISO | RGD:1347615 | 6480464 | linalool results in increased expression of INSIG1 protein | CTD | PMID:21944868 |
| lovastatin | increases expression | ISO | RGD:1347615 | 6480464 | Lovastatin results in increased expression of INSIG1 mRNA | CTD | PMID:19260826 |
| lovastatin | increases expression | EXP | | 6480464 | Lovastatin results in increased expression of INSIG1 mRNA | CTD | PMID:19260826 |
| metformin | increases expression | EXP | | 6480464 | Metformin results in increased expression of INSIG1 mRNA | CTD | PMID:23457588 |
| methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of INSIG1 mRNA | CTD | PMID:19465457 |
| microcystin-LR | increases expression | EXP | | 6480464 | cyanoginosin LR results in increased expression of INSIG1 mRNA | CTD | PMID:17383702 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:708457 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of INSIG1 mRNA | CTD | PMID:22129741 |
| N-ethyl-N-nitrosourea | decreases expression | ISO | RGD:708457 | 6480464 | Ethylnitrosourea results in decreased expression of INSIG1 mRNA | CTD | PMID:15954086 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:708457 | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of INSIG1 mRNA | CTD | PMID:22129741 |
| oxaliplatin | decreases expression | ISO | RGD:1347615 | 6480464 | oxaliplatin results in decreased expression of INSIG1 mRNA | CTD | PMID:16510598 |
| paclitaxel | affects response to substance | ISO | RGD:1347615 | 6480464 | INSIG1 protein affects the susceptibility to Paclitaxel | CTD | PMID:16217747 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of INSIG1 mRNA | CTD | PMID:17585979 |
| paracetamol | increases expression | ISO | RGD:708457 | 6480464 | Acetaminophen results in increased expression of INSIG1 mRNA | CTD | PMID:22112502 |
| perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:708457 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of INSIG1 mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:708457 | 6480464 | perfluorooctanoic acid results in decreased expression of INSIG1 mRNA | CTD | PMID:19162173 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of INSIG1 mRNA | CTD | PMID:19270015 |
| phenobarbital | increases expression | ISO | RGD:708457 | 6480464 | Phenobarbital results in increased expression of INSIG1 mRNA | CTD | PMID:19162173 |
| pirinixic acid | multiple interactions | ISO | RGD:708457 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of INSIG1 protein | CTD | PMID:19248225 |
| pirinixic acid | increases expression | ISO | RGD:708457 | 6480464 | pirinixic acid results in increased expression of INSIG1 mRNA | CTD | PMID:17126302 PMID:19162173 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of INSIG1 mRNA | CTD | PMID:17118139 |
| pirinixic acid | increases expression | ISO | RGD:708457 | 6480464 | pirinixic acid results in increased expression of INSIG1 mRNA | CTD | PMID:19162173 PMID:17126302 |
| piroxicam | multiple interactions | ISO | RGD:1347615 | 6480464 | Cisplatin affects the reaction [Piroxicam results in decreased expression of INSIG1 mRNA] | CTD | PMID:21858171 |
| piroxicam | decreases expression | ISO | RGD:1347615 | 6480464 | Piroxicam results in decreased expression of INSIG1 mRNA | CTD | PMID:21858171 |
| progesterone | increases expression | ISO | RGD:1347615 | 6480464 | Progesterone results in increased expression of INSIG1 mRNA | CTD | PMID:18070364 |
| quercetin 3-O-beta-D-glucoside | multiple interactions | ISO | RGD:1347615 | 6480464 | [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of INSIG1 mRNA | CTD | PMID:18032389 |
| raloxifene | increases expression | ISO | RGD:1347615 | 6480464 | Raloxifene results in increased expression of INSIG1 mRNA | CTD | PMID:16497877 |
| ranitidine | multiple interactions | ISO | RGD:708457 | 6480464 | Ranitidine inhibits the reaction [Lipopolysaccharides results in decreased expression of INSIG1 mRNA] | CTD | PMID:16415329 |
| resveratrol | multiple interactions | ISO | RGD:1347615 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of INSIG1 mRNA | CTD | PMID:19167446 |
| succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of INSIG1 mRNA | CTD | PMID:21641980 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:1347615 | 6480464 | tert-Butylhydroperoxide results in decreased expression of INSIG1 mRNA | CTD | PMID:15336504 |
| testosterone | multiple interactions | ISO | RGD:1347615 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of INSIG1 mRNA | CTD | PMID:21592394 |
| testosterone | increases expression | ISO | RGD:1347615 | 6480464 | Testosterone results in increased expression of INSIG1 mRNA | CTD | PMID:21592394 |
| tetrachloroethene | decreases expression | ISO | RGD:1347615 | 6480464 | Tetrachloroethylene results in decreased expression of INSIG1 mRNA | CTD | PMID:16010555 |
| tetrachloromethane | decreases expression | ISO | RGD:708457 | 6480464 | Carbon Tetrachloride results in decreased expression of INSIG1 mRNA | CTD | PMID:16239168 |
| tetrachloromethane | increases expression | ISO | RGD:708457 | 6480464 | Carbon Tetrachloride results in increased expression of INSIG1 mRNA | CTD | PMID:22112502 |
| topotecan | affects response to substance | ISO | RGD:1347615 | 6480464 | INSIG1 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 |
| trans-resveratrol | multiple interactions | ISO | RGD:1347615 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of INSIG1 mRNA | CTD | PMID:19167446 |
| troglitazone | multiple interactions | ISO | RGD:708457 | 6480464 | [troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of INSIG1 protein | CTD | PMID:19248225 |
| uranium atom | affects expression | ISO | RGD:1347615 | 6480464 | Uranium affects the expression of INSIG1 mRNA | CTD | PMID:15672453 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of INSIG1 mRNA | CTD | PMID:17292431 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of INSIG1 mRNA | CTD | PMID:22045034 |
| vanadium atom | decreases expression | ISO | RGD:1347615 | 6480464 | Vanadium results in decreased expression of INSIG1 mRNA | CTD | PMID:19000753 |
| vanadium(0) | decreases expression | ISO | RGD:1347615 | 6480464 | Vanadium results in decreased expression of INSIG1 mRNA | CTD | PMID:19000753 |
| vancomycin | increases expression | EXP | | 6480464 | Vancomycin results in increased expression of INSIG1 mRNA | CTD | PMID:18930951 |
| vanillin | decreases expression | ISO | RGD:1347615 | 6480464 | vanillin results in decreased expression of INSIG1 mRNA | CTD | PMID:17178418 |
| zinc atom | multiple interactions | ISO | RGD:1347615 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of INSIG1 mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:1347615 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of INSIG1 mRNA | CTD | PMID:18593933 |